407 related articles for article (PubMed ID: 18410455)
1. The use of intravenous iron in patients with cancer-related anaemia.
Littlewood TJ; Alikhan R
Br J Haematol; 2008 Jun; 141(6):751-6. PubMed ID: 18410455
[TBL] [Abstract][Full Text] [Related]
2. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
Mircescu G; Gârneata L; Capusa C; Ursea N
Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
[TBL] [Abstract][Full Text] [Related]
3. Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia: the need for predictors and indicators of effectiveness has not abated.
Katodritou E; Zervas K; Terpos E; Brugnara C
Br J Haematol; 2008 Jul; 142(1):3-10. PubMed ID: 18430192
[TBL] [Abstract][Full Text] [Related]
4. Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?
Macdougall IC
Curr Med Res Opin; 2010 Feb; 26(2):473-82. PubMed ID: 20014980
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
Qunibi WY
Arzneimittelforschung; 2010; 60(6a):399-412. PubMed ID: 20648931
[TBL] [Abstract][Full Text] [Related]
6. Current recommendations on iron therapy in anaemia of chronic renal failure.
Singh NP; Anuradha S; Agarwal SK
J Assoc Physicians India; 2002 Oct; 50():1295-302. PubMed ID: 12568217
[No Abstract] [Full Text] [Related]
7. [Use of intravenous iron in chronic renal patients with anemia. Higher levels of hemoglobin at a lower cost].
Cuero CJ; Pérez E; de Rivera C
Rev Med Panama; 1998; 23(1):14-6. PubMed ID: 10997188
[TBL] [Abstract][Full Text] [Related]
8. Benefits and risks of iron therapy for chronic anaemias.
Weiss G; Gordeuk VR
Eur J Clin Invest; 2005 Dec; 35 Suppl 3():36-45. PubMed ID: 16281957
[TBL] [Abstract][Full Text] [Related]
9. [Issues related to iron replacement in dialyzed patients].
Kessler M
Nephrol Ther; 2006 Sep; 2 Suppl 4():S266-73. PubMed ID: 17373269
[TBL] [Abstract][Full Text] [Related]
10. The use of intravenous iron in patients with cancer related anaemia: don't overlook iron deficiency anaemia in colorectal cancer.
Fitzgerald JE; Simpson JA; Acheson AG
Br J Haematol; 2008 Dec; 143(5):754; author reply 755. PubMed ID: 18950463
[No Abstract] [Full Text] [Related]
11. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
[TBL] [Abstract][Full Text] [Related]
12. Iron management in nondialysis-dependent CKD.
Fishbane S
Am J Kidney Dis; 2007 Jun; 49(6):736-43. PubMed ID: 17533016
[TBL] [Abstract][Full Text] [Related]
13. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?
Kalantar-Zadeh K; Streja E; Miller JE; Nissenson AR
Adv Chronic Kidney Dis; 2009 Mar; 16(2):143-51. PubMed ID: 19233073
[TBL] [Abstract][Full Text] [Related]
14. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
Bhandari S; Naudeer S
J Eval Clin Pract; 2008 Dec; 14(6):996-1001. PubMed ID: 18785894
[TBL] [Abstract][Full Text] [Related]
15. The safety of intravenous iron dextran (Dexferrum) during hemodialysis in patients with end stage renal disease.
Hood SA; O'Brien M; Higgins R
Nephrol Nurs J; 2000 Feb; 27(1):41-2. PubMed ID: 10852689
[TBL] [Abstract][Full Text] [Related]
16. [How do we need to maintain the iron status in dialyzed patients treated with erythropoesis stimulating agents].
Kes P; Basić-Jukići N; Jurić I
Acta Med Croatica; 2009 Sep; 63 Suppl 1():54-61. PubMed ID: 20232552
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous iron on haemodialysis catheter microbial colonization and blood-borne infection.
Brewster UC; Coca SG; Reilly RF; Perazella MA
Nephrology (Carlton); 2005 Apr; 10(2):124-8. PubMed ID: 15877670
[TBL] [Abstract][Full Text] [Related]
18. An economic evaluation of intravenous versus oral iron supplementation in people on haemodialysis.
Wong G; Howard K; Hodson E; Irving M; Craig JC
Nephrol Dial Transplant; 2013 Feb; 28(2):413-20. PubMed ID: 23182811
[TBL] [Abstract][Full Text] [Related]
19. Future directions in management of anemia in heart failure.
Agarwal AK; Katz SD
Heart Fail Clin; 2010 Jul; 6(3):385-95. PubMed ID: 20630412
[TBL] [Abstract][Full Text] [Related]
20. Anaemia management in cardio renal disease.
Silverberg DS; Wexler D; Iaina A; Schwartz D
J Ren Care; 2010 May; 36 Suppl 1():86-96. PubMed ID: 20586904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
